Idarubicin-containing regimen and G-CSF are capable of recruiting CD34+/DR- cells with high proliferative potential which sustain Ph-negative polyclonal hematopoiesis
Carella, A.M.; Podestá, M.; Pollicardo, N.; Pungolino, E.; Raffo, M.R.; Ferrero, R.; Bergamaschi, G.; Rosti, V.; Cazzola, M.; Saglio, G.
Leukemia 8(1): 212-213
1994
ISSN/ISBN: 0887-6924 PMID: 7507192 Document Number: 432956
Document emailed within 1 workday
Related Documents
Deriugina, E.I.; Drize, N.I.; Udalov, G.A.; Chertkov, I.L. 1988: The proliferative potential of hematopoietic stem cells (CFUs) during serial passage in irradiated mice as foci of ectopic hematopoiesis Biulleten' Eksperimental'noi Biologii i Meditsiny 106(12): 718-720Horie, S.; Minota, S.; Kano, S. 2000: Large macrophage colony-forming cells identical to high proliferative potential colony-forming cells in peripheral blood of patients with collagen vascular diseases: high occurrence among patients with systemic sclerosis and dermatomyositis Journal of Rheumatology 27(10): 2378-2381
Boggs, D.R.; Boggs, S.S. 1981: Proliferative potential of hematopoietic stem cells Problemy Gematologii i Perelivaniia Krovi 26(12): 30-33
Jiménez, S.; Zamora, J.; Muriel, A.; Pascual, J. 2008: Is it possible to sustain adequate immunosuppressive efficacy minimizing the nephrotoxicity with a regimen including low doses of calcineurin inhibitors or sirolimus? Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 28(Suppl 2): 40-41
Fermor, B.; Umpleby, H.C.; Lever, J.V.; Symes, M.O.; Williamson, R.C. 1986: Proliferative and metastatic potential of exfoliated colorectal cancer cells Journal of the National Cancer Institute 76(2): 347-349
Mandelli, F.; Testi, A.M.; Aloe Spiriti, M.A.; Giona, F.; Meloni, G.; Moleti, M.L.; Amadori, S.; Pacciarini, M.A. 1986: Evaluation of a polychemotherapeutic regimen including Idarubicin (4-demethoxydaunorubicin) in relapsed acute lymphocytic leukemia Haematologica 71(1): 34-38
Ferrari, G.; Greene, L.A. 1994: Proliferative inhibition by dominant-negative Ras rescues naive and neuronally differentiated PC12 cells from apoptotic death EMBO Journal 13(24): 5922-5928
Fraifeld, V.; Seidman, R.; Sagi, O.; Muradian, K.; Wolfson, M. 2001: Aurintricarboxylic acid decreases proliferative potential of SKOV3 and MCF7 human carcinoma cells Anticancer Research 21(3b): 1975-1978
Ratajczak, M.Z.; Skórski, T.; Kuczyński, W.I.; Ratajczak, J. 1993: The influence of 4 degrees C storage on proliferative potential of human bone marrow CD34+ cells. Transplantological implications Folia Histochemica et Cytobiologica 31(3): 109-112
Dumont, F.J. 1987: Stimulation of murine T cells via the Ly-6C antigen: lack of proliferative response in aberrant T cells from lpr/lpr and gld/gld mice despite high Ly-6C antigen expression Journal of Immunology 138(12): 4106-4113
Bartram, H.P.; Gostner, A.; Reddy, B.S.; Rao, C.V.; Scheppach, W.; Dusel, G.; Richter, A.; Richter, F.; Kasper, H. 1995: Missing anti-proliferative effect of fish oil on rectal epithelium in healthy volunteers consuming a high-fat diet: potential role of the n-3:n-6 fatty acid ratio European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 4(3): 231-237
Nadali, G.; de Wynter, E.A.; Perandin, F.; Tavecchia, L.; Vincenzi, C.; Ambrosetti, A.; Fornalè, M.; Perona, G.; Pizzolo, G.; Testa, N.G. 1998: Regulation of the proliferative potential of cord blood long-term culture-initiating cells (LTC-IC) by different stromal cell lines: implications for LTC-IC measurement Haematologica 83(12): 1059-1065
Imataki, O.; Aoyama, T.; Tamai, Y.; Kawakami, K. 2007: Comparison of regimen-related toxicity between high-dose melphalan and ICE as a preparatory regimen for autologous stem cell transplantation Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(10): 1633-1636
Traktuev, D.O.; Parfenova, E.V.; Tkachuk, V.A.; March, K.L. 2006: Adipose stromal cells--plastic type of cells with high therapeutic potential Tsitologiia 48(2): 83-94
Zucali, J.R.; Ulatowski, J.A.; Mirand, E.A. 1980: Erythroid progenitor cells and cells capable of producing erythropoietic activity from fetal mouse liver Experimental Hematology 8(8): 971-979
Broxmeyer, H.E.; Cooper, S. 1997: High-efficiency recovery of immature haematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopreserved for 10 years Clinical and Experimental Immunology 107 Suppl. 1: 45-53
Ezan, E.; Carde, P.; Le Kerneau, J.; Ardouin, T.; Thomas, F.; Isnard, F.; Deschamps de Paillette, E.; Grognet, J.M. 1994: Pharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesis Drug Metabolism and Disposition: the Biological Fate of Chemicals 22(6): 843-848
Fujita, H.; Ogawa, M.; Masaoka, T.; Yamada, K.; Kimura, K. 1992: A pharmacokinetic study of idarubicin hydrochloride, a new anthracycline anti-tumor drug, in patients with acute leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(6): 791-798
Ogawa, M.; Masaoka, T.; Yamada, K.; Kimura, K. 1993: Early phase Ii study of Idarubicin, a new anthracycline anticancer drug, in acute leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(7): 897-906
Quesniaux, V. 1994: Cytokines: regulators of hematopoiesis with promising therapeutic potential Praxis 83(45): 1247-1249